Showing results (1591-1600 of 1,710) with videos related to

Sort By:
Pageof 171
Journal of Clinical Microbiology|August 24, 2018
Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised PatientsMi Ra Ryu, Min-Seung Park, Eun Hye Cho, et al.
NPJ Digital Medicine|January 5, 2024
Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center studyKyung Hwa Lee, Gwang Hyeon Choi, Jihye Yun, et al.
Genome Medicine|January 6, 2022
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trialJung Yong Hong, Hee Jin Cho, Jason K Sa, et al.
Optics Letters|August 4, 2012
Investigating the interaction of x-ray free electron laser radiation with grating structureJérôme Gaudin, Cigdem Ozkan, Jaromír Chalupský, et al.
Digestive Diseases and Sciences|February 15, 2020
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort StudyDong Hyun Sinn, Hye Won Lee, Yong-Han Paik, et al.
European Journal of Cancer (Oxford, England : 1990)|August 27, 2021
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda, et al.
Diagnostic and Interventional Imaging|September 25, 2025
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosisYoungsu Park, Yuri Cho, Seung Up Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2020
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer TrialThomas Karn, Tobias Meissner, Karsten E Weber, et al.
Scientific Reports|June 6, 2023
Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusionNur P Damayanti, M Reza Saadatzadeh, Erika Dobrota, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2026
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approachJeong Ha Lee, Nalee Kim, Jeong Il Yu, et al.
Pageof 171